Table 1.
Participants’ sociodemographic and clinical characteristics. (n = 31).
| Sex | Female | 28 (90%) |
| Male | 3 (9%) | |
| Age | 18–49 | 15 (48%) |
| 50 and over | 16 (51%) | |
| Race/ethnicity | Black, Caribbean | 1 (3%) |
| East Asian | 2 (9%) | |
| Latin American | 1 (3%) | |
| Mixed heritage | 4 (12%) | |
| Southeast Asian | 1 (3%) | |
| White/European | 20 (64%) | |
| Other | 2 (6%) | |
| Education | College, High school, or less | 12 (38%) |
| Bachelor degree or postgraduate degree | 19 (61%) | |
| Income | $79,000 or less | 13 (41%) |
| $80,000 or more | 15 (48%) | |
| Country of Origin | Outside Canada | 15 (48%) |
| Canada | 16 (51%) | |
| Family history of cancer | Yes | 31 (100%) |
| Affected by cancer | Yes | 20 (64%) |
| No | 10 (32%) | |
| Unsure | 1 (3%) | |
| Cancer typea | Breast | 16 (51%) |
| Endometrial | 2 (6%) | |
| Ovarian | 2 (6%) | |
| Colon | 1 (3%) | |
| Thyroid | 1 (3%) | |
| BRCA1 and/or BRCA2 only | 16 (51%) | |
| Participant-reported past genetic testing | Hereditary breast and ovarian cancer genes, other than BRCA1/2 | 3 (9%) |
| BRCA1/2 and other hereditary breast and ovarian cancer genes | 4 (12%) | |
| Lynch syndrome | 3 (9%) | |
| Unsure | 5 (16%) |
aTwo patients were affected by multiple cancers (thyroid and endometrial, ovarian, and breast).